WOCKHARDT LTD. - 532300 - Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee Of The Board Of Directors Of Wockhardt Limited Held On March 3, 2022.
Outcome of the meeting of the Capital Raising Committee of the Board of Directors of Wockhardt Limited held on March 3, 2022. WOCKHARDT LTD. - 532300 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 01, 2022 for Themisto Trustee Company Pvt Ltd WOCKHARDT LTD. - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Capital Raising Committee Of The Board Of Directors Of The Company To Be Held On 3Rd March, 2022.
WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/03/2022 ,inter alia, to consider and approve Meeting of the Capital Raising Committee of the Board of Directors of the Company is scheduled to be held on Thursday, 3rd March, 2022, inter-alia, to consider and approve the terms and conditions of the rights issue and other related matters. WOCKHARDT LTD. - 532300 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the requirement of the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Link Intime India Private Limited, our Registrar & Share Transfer Agent (RTA) has intimated about receipt of request for issuance of Duplicate Share Certificate(s) in lieu of Original Share Certificate(s).
Wockhardt gets CDSCO approval to export Russian Covid vaccine Sputnik
The approval is for the export of up to 8 crore doses of Sputnik Light and up to 2 crore doses of Sputnik V Component I vaccines, Wockhardt Ltd said in a regulatory filing WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith the Press Release titled 'Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines', which is self-explanatory. WOCKHARDT LTD. - 532300 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the requirement of the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Link Intime India Private Limited, our Registrar & Share Transfer Agent (RTA) has intimated about receipt of request for issuance of Duplicate Share Certificate(s) in lieu of Original Share Certificate(s). WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 published today i.e. on 28th January, 2022 in Business Standard and Navshakti Wockhardt reports consolidated net profit of Rs 1.77 crore in Q3
New Delhi, Jan 27 Drug maker Wockhardt on Thursday reported a consolidated net profit of Rs 1.77 crore for the third quarter ended December 31, 202.. Q3FY22 Quarterly Result Announced for Wockhardt Ltd.
Pharmaceuticals company Wockhardt declares Q3FY22 result: Wockhardt’s Q3 FY22 Revenue grew by 12% over Q3 FY21 and EBITDA grew many fold at Rs.114 crore The Company recorded substantial growth in Revenue (up by 12% over previous corresponding quarter) and in EBITDA at Rs.114 crore compared to a profit of Rs.56 crore in the corresponding quarter of the previous year. There is Revenue growth of 21% in 9MFY22 over the previous year and substantial improvement in EBITDA at Rs.331 cr Result PDF